Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advances in Materials

• Publication date

  2016-11-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1002/adma.201603463PMID 27626769PMCID PMC5283718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles

  2016cited by this paper
• Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.

  2016cited by this paper
• Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots.

  2016cited by this paper
• Nanoparticle biointerfacing via platelet membrane cloaking

  2015cited by this paper
• Anticancer Platelet‐Mimicking Nanovehicles

  2015cited by this paper
• Engineered nanomedicine for myeloma and bone microenvironment targeting

  2014cited by this paper
• Clot-targeted micellar formulation improves anticoagulation efficacy of bivalirudin.

  2014cited by this paper
• Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting.

  2014cited by this paper
• ATP-triggered anticancer drug delivery

  2014cited by this paper
• Curing myeloma at last: defining criteria and providing the evidence.

  2014cited by this paper
• Injectable nano-network for glucose-mediated insulin delivery.

  2013cited by this paper
• A biomimetic nanosponge that absorbs pore-forming toxins

  2013cited by this paper
• Lenalidomide after stem-cell transplantation for multiple myeloma.

  2012cited by this paper
• Latest advances and current challenges in the treatment of multiple myeloma

  2012cited by this paper
• Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

  2012cited by this paper
• Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels

  2012cited by this paper
• Thrombosis is associated with inferior survival in multiple myeloma

  2012cited by this paper
• Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

  2011cited by this paper
• Thrombosis in multiple myeloma.

  2010cited by this paper
• Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

  2010cited by this paper
• Treatment of multiple myeloma: a comprehensive review.

  2009cited by this paper
• Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

  2009cited by this paper
• A shear gradient–dependent platelet aggregation mechanism drives thrombus formation

  2009cited by this paper
• Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy

  2009cited by this paper
• Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

  2008cited by this paper
• Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature.

  2008cited by this paper
• Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications.

  2008cited by this paper
• Mechanisms of thrombus formation.

  2008cited by this paper
• Thrombosis in multiple myeloma

  2007cited by this paper
• Bortezomib for the Treatment of Mantle Cell Lymphoma

  2007cited by this paper
• Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.

  2005cited by this paper
• Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles.

  2005cited by this paper
• Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes

  2003cited by this paper
• Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

  2003cited by this paper
• Platelets in atherothrombosis

  2002cited by this paper
• CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells

  2002cited by this paper
• Multiple myeloma: evolving genetic events and host interactions

  2002cited by this paper
• Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

  2001cited by this paper
• Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor (*)

  1995cited by this paper
• Identification of an Inhibitor of Tissue-type Plasminogen Activator-mediated Fibrinolysis in Human Neutrophils

  1995cited by this paper

• Genetically Encoded Multivalent Elastin-Like Polypeptide-Haemadin Fusion Proteins for Prolonged Antithrombotic Protection.

  2026cites this paper
• A magnetic hyperthermia-chemodynamic nanoreactor with ascorbic acid-enhanced reactive oxygen species regulation for anti-thrombosis therapy

  2026cites this paper
• Synergistic activation of the bioenergetics-apoptosis axis via flavonoids-loaded cascade-targeted biomimetic nanoplatform to overcome cancer metabolic plasticity

  2026cites this paper
• Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood-Brain Barrier.

  2026cites this paper
• In situ coagulation environment regulation–assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics

  2026cites this paper
• Mesenchymal stem cell membrane-coated kaempferol biomimetic nanoformulation for the treatment of atherosclerosis.

  2026cites this paper
• Hyaluronic acid-based supramolecular peptide-drug conjugate prodrug nanosystems for precise multiple myeloma therapy

  2026cites this paper
• Nanomedicines: An Update of Diagnostic and Therapeutic Applications in Multiple Cancers.

  2026cites this paper
• Engineering platelets as cancer therapeutics.

  2026cites this paper
• Saga of MCL1 inhibitors in multiple myeloma.

  2025cites this paper
• "Platelets as Circulatory Drug Carriers: Emerging Potential and Its Advantages Over Conventional Delivery Systems"

  2025cites this paper
• Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities

  2025cites this paper
• Engineered Biomimetic Nanomedicine for Enhanced Bone Marrow Targeted Delivery and Therapy in Multiple Myeloma

  2025cites this paper
• Advances in nanocarriers for targeted drug delivery and controlled drug release.

  2025cites this paper
• Nanoparticle delivery systems mitigate hemorrhagic complications following tPA-induced thrombolysis

  2025cites this paper
• Recent advances in microneedles for enhanced functional angiogenesis and vascular drug delivery.

  2025cites this paper
• NIR‐II Imaging‐Guided Self‐Penetrating Nanomotors for Millimeter‐Scale Deep Thrombolysis Tracking and Accelerated Embolus Clearance

  2025cites this paper
• Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Platform for Tumor Therapy

  2025cites this paper
• HIFU‐Driven Targeted Pyroptosis Therapy in Basal‐Like Breast Cancer

  2025cites this paper
• Biomimetic drug delivery for anticancer: Focusing on the relationship between drugs and biomimetic carriers

  2025cites this paper
• Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery

  2025cites this paper
• Magnetic Micro/nanorobots in Cancer Theranostics: From Designed Fabrication to Diverse Applications.

  2025cites this paper
• Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases

  2025cites this paper
• NIR‐Driven Nanomotors Integrating With Platelet‐Thylakoid Hybrid Membranes for Synchronized Thrombolysis and Vascular Remodeling

  2025cites this paper
• Application of aggregation-induced emission materials in gastrointestinal diseases

  2025cites this paper
• Fusing Biomimetic Engineering with Nanotechnology: The Rise of Platelet Membrane‐Coated Nanoparticles as a Versatile Platform for Biomedical Innovation

  2025cites this paper
• From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery

  2025cites this paper
• Advanced Applications of Nanomaterials in Atherosclerosis Diagnosis and Treatment: Challenges and Future Prospects.

  2024cites this paper
• Microbubble Biointerfacing by Regulation of the Platelet Membrane Surfactant Activity at the Gas-Liquid Interface for Acute Thrombosis Targeting.

  2024cites this paper
• Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications

  2024cites this paper
• Advancements in drugs restructured with nanomedicines for multiple myeloma treatment

  2024cites this paper
• Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

  2024cites this paper
• Engineering Cells for Cancer Therapy.

  2024cites this paper
• Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection

  2024cites this paper
• Current advance of nanotechnology in diagnosis and treatment for malignant tumors

  2024cites this paper
• Autologous material-inspired drug delivery systems

  2024cites this paper
• Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen-Glucose Deprivation.

  2024cites this paper
• Platelet-inspired targeting delivery for coronary heart disease

  2024cites this paper
• Black Phosphorus-Loaded Manganese Nanosystem Embedded in Thermosensitive Polymer Gels as an Injectable Platform for Osteosarcoma Therapy

  2024cites this paper
• The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment.

  2024cites this paper
• Advances in biomimetic nanomaterial delivery systems: harnessing nature's inspiration for targeted drug delivery.

  2024cites this paper
• Bioinspired and bioengineered nucleic acid drug carriers

  2024cites this paper
• An intelligent DNA nanodevice for precision thrombolysis

  2024influential citation
• AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer

  2024cites this paper
• Platelet-based bioactive systems guided precision targeting and immune regulation for cancer therapy

  2024cites this paper
• Harnessing Engineered Extracellular Vesicles from Mesenchymal Stem Cells as Therapeutic Scaffolds for Bone‐Related Diseases

  2024cites this paper
• Current status and future perspectives of platelet-derived extracellular vesicles in cancer diagnosis and treatment

  2024cites this paper
• Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia.

  2024cites this paper
• Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma.

  2023cites this paper
• Temporal and spatial variations of pelagic microbial water quality in a coastal river-wetland area in a temperate climate zone

  2023cites this paper
• “Bioinspired” Membrane-Coated Nanosystems in Cancer Theranostics: A Comprehensive Review

  2023cites this paper
• Platelets for advanced drug delivery in cancer

  2023cites this paper
• Recent Advances in Cell-based Nanotherapy for Cardiovascular Diseases.

  2023cites this paper
• A Machine‐Learning‐Based Bibliometric Analysis of Cell Membrane‐Coated Nanoparticles in Biomedical Applications over the Past Eleven Years

  2023cites this paper
• Anti-BCMA surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo.

  2023cites this paper
• Nucleus-Targeting Manganese Dioxide Nanoparticles Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane for Cancer Cell Therapy

  2023cites this paper
• Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics

  2023cites this paper
• Active recruitment of anti–PD-1–conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapy

  2023cites this paper
• Cell Membrane-Derived Nanovehicles for Targeted Therapy of Ischemic Stroke: From Construction to Application

  2023cites this paper
• Bleeding and Thrombosis in Multiple Myeloma: Platelets as Key Players during Cell Interactions and Potential Use as Drug Delivery Systems

  2023cites this paper
• Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective

  2023cites this paper
• Cell membrane biomimetic nanoparticles in drug delivery

  2023cites this paper
• Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities

  2023cites this paper
• Biomimetic approaches for targeting tumor inflammation.

  2022cites this paper
• AIEgen-Based Bionic Nanozymes for the Interventional Photodynamic Therapy-Based Treatment of Orthotopic Colon Cancer

  2022cites this paper
• A neurovascular dual-targeting platelet-like bioinspired nanoplatform for ischemic stroke treatment

  2022cites this paper
• Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques

  2022cites this paper
• Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment.

  2022cites this paper
• Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.

  2022cites this paper
• Bio‐Orthogonal Chemistry in Cell Engineering

  2022cites this paper
• Multifaceted Engineered Biomimetic Nanorobots Toward Cancer Management.

  2022cites this paper
• Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma

  2022cites this paper
• Biomimetic platelet membrane-coated Nanoparticles for targeted therapy.

  2022cites this paper
• Potential nanotherapeutic strategies for perioperative stroke

  2022cites this paper
• Engineered platelets-based drug delivery platform for targeted thrombolysis

  2022cites this paper
• Pathogenesis and treatment of multiple myeloma

  2022cites this paper
• Nanotechnology for stroke treatment

  2022cites this paper
• Bio-inspired nanoparticles as drug delivery vectors

  2022cites this paper
• Biomimetic cell membrane‐coated poly(lactic‐ co ‐glycolic acid) nanoparticles for biomedical applications

  2022cites this paper
• Targeting drugs to tumours using cell membrane-coated nanoparticles

  2022cites this paper
• Platelet-Covered Nanocarriers for Targeted Delivery of Hirudin to Eliminate Thrombotic Complication in Tumor Therapy.

  2022cites this paper
• Harnessing Protein Corona for Biomimetic Nanomedicine Design

  2022cites this paper
• Emerging advances in engineered macrophages for tumor immunotherapy.

  2022cites this paper
• Precise fibrin decomposition and tumor mechanics modulation with hydroxyethyl starch-based smart nanomedicine for enhanced antitumor efficacy.

  2022cites this paper
• NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases

  2022cites this paper
• Cancer Cell Membrane Cloaked Nanocarriers: A Biomimetic Approach Towards Cancer Theranostics

  2022cites this paper
• Platelets and platelet extracellular vesicles in drug delivery therapy: A review of the current status and future prospects

  2022cites this paper
• Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.

  2022cites this paper
• Nanoparticle-based medicines in clinical cancer therapy

  2022cites this paper
• Advances in cell membrane-coated nanoparticles and their applications for bone therapy.

  2022cites this paper
• Cell membrane-encapsulated nanoparticles for vaccines and immunotherapy

  2021cites this paper
• Progress of biomaterials for bone tumor therapy

  2021cites this paper
• Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment

  2021cites this paper
• Near-Infrared Light and Upconversion Nanoparticle Defined Nitric Oxide-Based Osteoporosis Targeting Therapy.

  2021cites this paper
• Cell/Bacteria‐Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy

  2021cites this paper
• Biomimetic liposomes hybrid with platelet membranes for targeted therapy of atherosclerosis

  2021cites this paper
• Injectable Hydrogel for Synergetic Low Dose Radiotherapy, Chemodynamic Therapy and Photothermal Therapy

  2021cites this paper
• New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases

  2021cites this paper
• Cancer-associated-platelet-inspired nanomedicines for cancer therapy.

  2021cites this paper
• Red blood cell membrane-camouflaged nanoparticles loaded with AIEgen and Poly(I : C) for enhanced tumoral photodynamic-immunotherapy

  2021cites this paper